Shanghai Junshi Biosciences Co., Ltd. Class H (HK:1877) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Shanghai Junshi Biosciences Co., Ltd. successfully passed all resolutions at its 2024 first extraordinary general meeting, including the use of over-subscription proceeds and changes to its registered address and Articles of Association. The meeting saw a significant turnout of shareholders, demonstrating strong support for the company’s strategic directions. This outcome indicates confidence in the company’s future plans and potential growth.
For further insights into HK:1877 stock, check out TipRanks’ Stock Analysis page.